In clinical practice, NT-proBNP is predominantly recognized as a marker for diagnosing and managing heart failure [4], since elevated levels of this peptide indicate an increased strain on the cardiac walls, which is commonly seen in conditions such as heart failure, acute coronary syndromes, and atrial fibrillation [4]. The gene discussed is NPPB; the disease is atrial fibrillation.